Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Pharming Group ( (PHGUF) ) just unveiled an announcement.
Pharming Group has nominated Fabrice Chouraqui as its new Executive Director and CEO, succeeding Sijmen de Vries. Chouraqui, with a strong background in the pharmaceutical and biotechnology industries, is expected to drive the company’s growth strategy in the rare disease market. This leadership change signifies Pharming’s commitment to expanding its market position and enhancing its product portfolio under Chouraqui’s guidance.
More about Pharming Group
Pharming Group is a biopharmaceutical company listed on Euronext Amsterdam and Nasdaq. It focuses on developing innovative products for rare diseases, aiming to become the company of choice in this sector.
YTD Price Performance: -3.86%
Average Trading Volume: 1,965
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $635.3M
See more data about PHGUF stock on TipRanks’ Stock Analysis page.
